AstraZeneca Settles Bulk Of Seroquel Diabetes Claims
AstraZeneca Pharmaceuticals LP has resolved nearly all suits accusing its blockbuster schizophrenia and bipolar disorder drug Seroquel of increasing the risk of diabetes, settling many claims brought in Florida multidistrict litigation...To view the full article, register now.
Already a subscriber? Click here to view full article